A MULTINOMIAL LOGIT MODEL OF CONSUMER PERCEPTIONS FOR BIOTECH FOOD LABELING by Han, Jae-Hwan & Harrison, R. Wes
 
 
 
A Multinomial Logit Model of Consumer Perceptions for Biotech Food Labeling 
 
 
by 
 
Jae-Hwan Han and  R.Wes.Harrison 
 
May 14, 2004 
 
Dept. of Agricultural Economics and Agribusiness 
101 Ag Administration Building, Louisiana State University 
Baton Rouge, LA 70803-5604 
Tel: (225) 578-2728 
Fax: (225) 578-2716 
e-mail: jhan4@lsu.edu  and wharrison@agctr.lsu.edu 
 
 
 
 
 
 
 
Selected Paper prepared for presentation at the American Agricultural Economics Association Annual 
Meeting, Denver, Colorado, August 1-4, 2004 
 
 
 
 
 
 
 
 
 
Copyright 2004 by JaeHwan Han and R.Wes.Harrison. All rights reserved. Readers may make verbatim copies of 
this document for non-commercial purposes by any means, provided that this copyright notice appears on all such 
copies. 
 
 
   1 
A Multinomial Logit Model of Consumer Perceptions for Biotech Food Labeling 
The voluntary labeling system established by the U.S. Food and Drug Administration 
(FDA) in 1973 was replaced by the Nutritional Labeling Education Act (NLEA) of 1990. 
NLEA requires mandatory labeling for all packaged foods and strict regulations regarding 
health claims and nutritional contents. The U.S. Office of Technology Assessment defined 
biotechnology as “any technique that uses living organisms (or parts of organisms) to make or 
modify products, to improve plants or animals, or to develop micro-organisms for specific 
uses.”(U.S. Congress, 1984:3)
1. For example, animals may be genetically engineered to 
encourage growth and to have better quality characteristics. Bovine Somatotropin (BST) or 
bovine growth hormone is a naturally occurring protein made in the pituitary gland of the cow. 
Recombinant bovine somatotrophin (rBST) is BST produced by genetically modified bacteria 
in the laboratory (Aldrich and Blisard, 1998). A cow administered with rBST can produce 20% 
more milk than cows not give rBST (Schacter, 1995).  
Most biotech products in the U.S. are not labeled as such, because FDA and the United 
States Department of Agriculture (USDA) require labeling only if biotech foods are determined 
materially different from conventional counterparts. Material differences contain different 
nutritional properties and safety contents from existing products, an allergen that consumers 
would not normally be presented based upon the name of the food, and so on. The current U.S. 
policy is based on the rationale that scientific results can confirm whether or not biotech 
products are materially different from traditional counterparts.  
Some consumers view biotechnology as a risky process, and have hightened interest in 
food safety and qualities issues associated with biotech food. Some consumers concerned about 
                                                 
1 The terms biotechnology, biotech, genetically modified, and genetically engineered are used interchangeably in 
this paper.   2 
potential unknown health risks that science might not detect argue for the “right to know” 
whether or not products are produced using biotechnology. These concerns are related to 
perception of unknown health and safety risks. Since preferences for labeling come from the 
consumers’ desire to make an informed buying decision for biotech product. Uncertainties will 
have an impact on consumers’ choice for biotech product labeling.  
Public Discussion 
Based on the timing and type of information available to consumers, food products can 
be characterized as falling into three categories: these include search goods, where consumers 
can ascertain the attributes (or quality) of a product before they buy and consume it; experience 
goods, where consumers can judge the attributes of a product after they buy and consume it; 
and, credence goods, where consumers can not accurately determine the attributes of a product 
even after they inspect, buy, and consume it (Nelson, 1970; Darby and Karni, 1973). It is 
assumed that consumers would have considerable difficulty and could not measure the 
attributes of biotech products even after consumption. Most biotech attributes fall in the 
credence good category (Isaac and Phillips, 1999).  
Concerns regarding biotechnology stem from potential unknown effects due to 
modifications of genes and nutritional content, environmental quality, morality and animal 
welfare owing to transgene and mistreatment of animals, and so on.  According to a study by 
Hoban and Kendall (1992), about forty seven percent of respondents have heard about 
biotechnology. Respondents indicated they feel that transferring genes from plants to plants is 
acceptable, but transferring it from animals to plants, animals to animal, and human to animal is 
unacceptable. Opponents of biotechnology argue that the unknown risks outweigh the benefits.   3 
Proponents tend to place greater weight on the benefits of the biotechnology (Wansink and 
Kim, 2001).  
The issue of labeling biotech products is also being debated in many countries. The 
European Union, (EU), Australia, Canada, New Zealand, and Japan regulate genetically 
modified products in specific ways. The European Union (EU), with some exceptions, requires 
labeling on food containing ingredients genetically modified and produced through genetic 
modification techniques, and some European countries, such as Austria and Luxembourg, do 
not allow import and use of agricultural biotechnology (AB) products (Cunningham and 
Unnevehr, 1999; Shoemaker and et al, 2001). It is likely that when EU would require 
segregation of biotech products from non-biotech products, that will cause tremendous 
marketing costs to U.S. export, due to separate shipping, inspection, and handling cost besides 
different labeling cost.    
The objective of this study to examine the relationship between consumers’ risk 
perceptions of biotech products and their attitude toward the current U.S. labeling policy and 
purchasing behavior for GM foods  
 
Literature Review 
From an economic perspective, Caswell and et al. (1994) studied the development of 
agricultural biotechnology. Caswell and et al. said that the success of biotech products depends 
upon some factors, such as public policies, producer’s expectation, and consumer demand on 
biotech products. The study suggested that if profitability of using the biotechnology is 
expected to be high, then demand for that by farmers and processors would increase. Caswell   4 
and et al. indicated that consumer demand on biotech products would, eventually, determine the 
demand of biotechnology in the farm sector. 
Caswell (1999) stated that the initial direction and speed of development of market for 
foods produced using genetically modified organism (GMOs) are significantly influenced by 
the choice of labeling policy. However, Caswell argued that there are a few realistic and 
economic reasons for not requiring all information to be disclosed on food labels. For example, 
those include substantial difficulty to separate biotech ingredients from non-biotech 
ingredients, increased marketing cost due to segregation of biotech products from non-biotech 
products, and limit of information to display on a label.   
Using nationwide consumer survey data, Grobe and et al. (1996) studied consumer risk 
perception associated with genetically modified product, recombinant Bovine growth 
hormone(rbGH), which is a food-related biotechnology used in milk production. The study 
investigated how consumers react to different typologies of risk perception toward the use of 
rbGH, and found the characteristics of consumers at each risk perception typology. Taking 
account of the complexity and unfamiliarity of biotechnology, consumers are distinguished into 
two groups. One group is about those with prior knowledge about rbGH’s use, and the other 
group is those who are not conscious of rbGH’s use. Grobe and et al. demonstrated that 
consumers with similar information showed the various risk perceptions. Consumer groups 
with shared information on rbGH displayed incoherent beliefs and roles relating to their own 
preferences. In addition, the study found that those who engaged in self-protective action were 
strongly correlated with environmentalist concerns. 
Investigated are consumers’ perceptions toward biotechnology in fifteen developed 
countries including U.S. and France. Hoban (1999) demonstrated that consumers from different   5 
areas of the world have quite diverse perceptions and understanding toward biotechnology. The 
study showed that consumer perceptions about biotech products are very different depending 
on type of information, government credibility, and cultural preferences. Especially, U.S. 
showed strong public support for biotechnology applications in comparison to other European 
countries. Most U.S. consumers expressed the circumspect optimism about benefits of 
biotechnology, and they will accept the biotech products if the price is appropriate and 
biotechnology benefits society. 
FDA (2000) examined consumer perceptions and awareness in four cities: Calverton, 
MD; Burlington VT; Seattle, WA; and Kansas City, MS. Most of participants said that to tell 
whether a food is produced using biotechnology, all foods should be labeled. Their concern for 
labeling was not in specific effect of biotechnology but in unknown long-term health and safety 
risk which motivates the demand for biotechnology labeling. In terms of labeling approach, 
nearly all participants recognized value in having “mere disclosure” labeling, and many of them 
were aware of symbolic value when they decided not to purchase biotech products. In regarad 
to the practicability of labeling, most participants expressed that labeling should be simple and 
effective. This suggests that too wordy and complicated labeling might put burden on consumer 
to get more informed. 
According to Hallman and Metcalfe (1995), eighty four percent of respondents 
supported special labels, that is, mandatory labeling, on biotech products. Sixty percent of 
participants answered that they would consider purchasing biotech vegetables if those are 
labeled as having been produced using biotechnology. Fifty eight percent said that they would 
spend time for looking at biotech labels while shopping. Forty two percent of respondents who   6 
said that they would search for produce labeled “not genetically engineered” also stated that if 
label conveys the information of biotech produce, then they would buy produce. 
Mojduszka and Caswell (2000) examined the effectiveness of markets in providing 
information to consumers on nutritional quality of processed foods. The study found that 
voluntary labeling on nutritional quality of processed foods was ineffective. Mojduszka and 
Caswell demonstrated that incentives for voluntary labeling of nutrient content by food 
processing company did not provide the consistent and effective quality signals to consumers. 
Thus, Mojduszka and Caswell suggested that it is more likely that mandatory labeling for 
nutrition quality, in comparison with voluntary labeling, increases the information available to 
consumers. The other study investigated the impact of food labels on consumers’ intake of 
selected nutrients. Kim and et al. (2000) has compared the nutrient intakes of label users with 
the expected nutrient of intakes of label users in the absence of labels. The study showed that 
the use of mandatory labeling on nutrients reduced the average daily calories from total fat by 
2.10 percentage points, the average daily cholesterol intake by 67.60 milligrams, and the 
average daily sodium intake by 29.58 milligrams. Kim and et al. demonstrated that mandatory 
labeling on the selected nutrients improved the intakes by consumers. The study provided the 
evidence that mandatory labeling is more likely to provide health benefits and society welfares, 
compared to voluntary labeling. However, none of the studies, including those of both 
Mojduszka and Caswell and Kim et al., has not been found to compare voluntary with 
mandatory labeling on biotech products.  Thus, the present study is worthy in that consumer’s 
preferences for voluntary and mandatory labeling and their purchasing behavior on biotech 
products are analyzed.  
   7 
Methodology  
The multinomial logit model (MLM) is appealing for this study for three reasons. First, 
data for the study consist of individual specific characteristics, and the MLM is well suitable to 
analyze the characteristics of the individual. If the data is composed of alternative specific 
attributes, then the conditional logit model (CLM) is appropriate. Secondly, while the MLM is 
most popular as discrete choice model, it has a strict restriction in use. An assumption of both 
MLM and CLM is that the alternatives are distinct and independent of one another. That is, 
introducing a new alternative leaves the relative odds of choosing among the existing 
alternatives unchanged. This property is called the independence of irrelevant alternatives (IIA) 
assumption. The IIA assumption follows from the assumption that the stochastic disturbances 
are independent and identically distributed. However, if alternatives are close substitutes for 
one another, then the IIA assumption is violated. The MLM has suffered from the IIA 
assumption in many areas by restricting the correlation patterns among choice alternatives. The 
IIA assumption, however, can only be empirically tested when some respondents have different 
choice sets. That is, when everyone in the sample is presented with the same choice set, the IIA 
assumption is not a serious problem (Allison, 1999). For the study, six alternatives are 
presented to all individuals. Thus, this study is free from IIA assumption. In addition, the MLM 
is easy to estimate even for a large number of alternatives (Borsch-Supan, 1990). Third, one of 
the alternatives to the MLM is the nested logit model (NLM) developed by McFadden (1978), 
which relaxes the IIA restriction of the MNL by allowing alternatives to be correlated across, 
but not within, groups (Greene, 2003). However, if a larger number of independent variables 
are included, the NLM is difficult to employ. For the study, four types of independent variables 
are considered. The number of those variables is as follows: six variables for consumers’ risk   8 
perception toward biotech foods, nine variables for socioeconomic/demographics factors, one 
variable for consumer awareness of biotech foods, and one variable for consumer use of food 
labels. Generally, it is recommended that seven variables plus or minus two are appropriate in 
nested logit models (George Institute Technology), so we use the MLM. 
The basic framework for analysis is provided by the random utility model where 
consumers are assumed to choose among a range of discrete number of alternatives to 
maximize their utility. Random utility theory states that a consumer’s utility can be 
decomposed into a systematic and random component of utility. That is, total utility is the sum 
of observable and unobservable components, 
                                U choice j i V ij ij ij ( )    for individual  = + e                         (1)            
The utility level Uij, which is individual i’s utility from choosing alternative j, is determined by 
the systematic component of utility of Vij and random components, eij, which is assumed to be 
independently and identically distributed with type I extreme value (Gumbel) distribution 
(Greene,2003). The random component represents the unknown components the consumers’ 
utility function. Consumer i chooses alternative j if 
                                           U U k j ij ik > „  for all                        (2)   
The probability of individual i choosing alternative j is equal to the probability that the utility of 
alternative j is greater than the utilities of all other alternatives in the choice set(Greene 2003). 
                                     P U U k j ij ij ik = > " „ Pr( )                           (3) 
The general form of the MLM model is described as 
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where Pij is the probability that individual i chooses alternative j. The xi is a vector of 
characteristics of individual i, J is the number of unordered alternatives, ßj  measures the 
contribution of personal characteristic i to the probability of choosing alternative j, and ßk 
measures the contribution of personal characteristic i to the probability of selecting alternative 
k. 
The log-likelihood function for the multinomial logit model is given by 
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where dij=1 if individual chooses i chooses alternative j and dij=0 otherwise (Greene, 2003). 
Empirical Model 
The MLM is used to investigate the significance of selected factors on individuals’ 
purchasing behavior and labeling preferences on biotech foods. The model was estimated 
separately for two different types of biotech foods, nonmeat and meat products.  
The model can be expressed as follows: 
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where J is the dependent variable and the number of alternatives in the choice set. Respondent 
are asked to choose between a voluntary labeling and a mandatory labeling policy for biotech 
food. Another question asks respondents if they are willing to buy nonmeat and meat products 
produced using biotechnology. The model is estimated with six alternatives: j=1 if the 
respondent indicated they prefer voluntary labeling and they would buy a biotech food; j=2 if 
the respondent indicated they prefer mandatory labeling and they would buy a biotech food; j=3 
if the respondent indicated they prefer voluntary labeling and they would not buy a biotech   10 
food; j=4 if the respondent indicated they prefer mandatory labeling and they would not buy a 
biotech food; j=5 if the respondent indicated they prefer voluntary labeling and they are 
uncertain about buying biotech food; j=6 if the respondent indicated they prefer mandatory 
labeling and they are uncertain about buying biotech food. The second alternatives, j=2, which 
is that the respondent indicated they prefer mandatory labeling and they would buy a biotech 
food, is used as the reference choice. The independent variables, xi, hypothesized to influence 
the alternatives are summarized as follows: (1) consumers’ perceptions variables toward 
biotech foods; (2) socioeconomic and demographic factors; (3) variables in regard to 
consumers’ use of food label; (4) consumer awareness variable of biotech foods. ßj  is a vector 
of the estimated parameters, and Pr[Yi=j] is the probability of individual i choosing j alternative 
among six alternatives in the choice set. 
Coefficients of the MLM are difficult to interpret because of the proliferation of 
parameters, which results in increased complexity in interpreting the estimates (Greene, 2003). 
The, marginal effects of the MLM are also difficult to derive. For continuous variables, 
marginal effects are calculated as follows:  
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The derivatives of the probabilities of the alternatives with respect to each of the explanatory 
variables are obtained at the sample means of the explanatory variables. For the binary 
explanatory variables, the difference between two computed probabilities is acquired at the 
sample means of all other explanatory variables, one conditional on the variable being equal to 
unity and one conditional on the variable being equal to zero. 
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where Pr(y=m|x, xk) is the probability that y=m among J alternatives given x, xS (starting value) 
= 0 and xE(ending value) = 1(Long, 1997). 
However, calculating marginal probabilities are not very useful to evaluate the 
magnitude of ß in MLM. First of all, discrete change represents the change for a particular set 
of values of the independent variables. Thus, the changes will not be the same at different 
levels of the variables. Another problem with marginal probability is that the dynamics among 
the dependent outcomes can not be captured from measures of discrete change (Long, 1997). 
Therefore, for the study, results are interpreted using the odds ratio, which is the exponentiated 
coefficient. The odds ratio is calculated by contrasting each category with the reference 
category. The odds ratio shows a multiplicative change in the odds for a unit change in an 
independent variable. 
For the binary logit model, 
                                              log( )
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P
x
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where xß is vector of independent variables and the estimated parameters. 
This ratio is called the odds, thus the left-hand side of (9) equation is referred to the log of odds 
or logit. The logistic coefficient is interpreted as the change in the logit associated with a one-
unit change in the independent variable, holding all other variables constant. The exponential of 
the logistic coefficient is the effects on the odds rather than probability. It is interpreted as for a 
one unit change in the independent variable, the odds are expected to change by a factor of 
exp(ß) when other things are equal. 
The multinomial logit is an extension of binary logit. For multinomial logit, the odds of 
outcome of m versus outcome n given x, specified by ? m|n(x), is as follows:   12 
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where m is one of the six alternatives, and n is a reference category. 
This equation can be expressed as  
                          W mn i i m n | ( ) exp( [ ]) x x = - b b                            (11) 
Taking logs demonstrates the multinomial logit is linear in the logit: 
                            ln ( ) ( ) | W mn i i m n x x = - b b                                 (12) 
The difference ßm- ßn is called a contrast, which is the effect of x on the logit of outcome m 
versus outcome n (Long, 1997). 
The exponential of positive number is greater than one, and the exponential of negative 
number is less than one. Thus, the threshold between positive and negative effect is one in 
interpreting odds ratio. If exponentiated coefficient is greater than one, that implies increased 
odds. On the other hand, as exponentiated coefficient between zero and one, odds decrease. The 
distance of exponentiated coefficient from one in either direction explains the size of the effect 
on the odds for unit change in the independent variable (Pampel, 2000).  Alternatively, the 
percentage change in the odds can be calculated (Long, 1997) as follows: 
          The Percentage Change in the Odds  = - 100 1 [exp( ) ] bk            (13) 
The equation (13) is interpreted as the percentage change in the odds in independent variable, 
holding all other variable constant. 
The dependent variable, y, is defined as six alternatives as was mentioned earlier. 
Thus, yij=1 if the i individual chooses alternative j, otherwise 0. Independent variables, x, 
characterize consumers’ perceptions toward biotech foods, consumer use of food labels, 
demographics, and consumer awareness of biotech foods. Variables indicating consumers’   13 
perceptions of biotech products are those regarding human health, morality, environmental 
biodiversity, religious motivation, and so on. Frequency of food label use of respondents is the 
other explanatory variable. Demographic variables are gender, age, income, marital status, and 
etc.. Consumer awareness factor of biotech foods are the level of being informed. 
The coding for demographic variables is as follows: Ageij=1 if the i
th respondent’s age 
corresponds to the j
th group, otherwise Ageij=0; Incij=1 if i
th respondents’ income falls into j
th 
category, otherwise Incij=0; Ethij =1 if the i
th respondent’s race corresponds to j
th category, 
otherwise Ethij =0; Eduij=1if the i
th respondents’ education level indicates the j
th category, 
otherwise Eduij=0; Mari=1 if i
th respondent is married, otherwise Mari= 0; Malei=1 if the i
th 
individual is male, otherwise malei= 0; Infant=1 if i
th respondent has infants, otherwise 
Infant=0; and Awarenessi =1 if i
th respondent is more than somewhat informed about biotech 
foods, otherwise = Awarenessi =0. In addition, the coding for respondents’ perceived level of 
risks and benefits associated with biotechnology is expressed as ranging from 5 ( strongly 
agree) to 1(strongly disagree). The coding for consumer use of food labels is represented as 
raging from 5 (never) to 1 (always). 
 
The Questionnaire and Data Collection 
A questionnaire was developed that included questions on mandatory and voluntary 
labeling preferences; questions on consumer awareness of biotech foods; questions on 
consumer risk perceptions of biotech foods; questions on purchasing biotech foods; questions 
regarding the consumers’ use of food labels; and questions on consumer demographic.  
The first part of the questionnaire presented background information on biotechnology. 
It contains a definition of biotechnology, present and future uses (benefits), and example of   14 
present application of biotechnology. This was followed by several questions in regard to the 
respondents’ general knowledge of, and their attitudes toward biotechnology. In the following 
section respondents were asked whether they are in favor of either voluntary or mandatory 
labeling policy for biotech products. Next section describes a question on consumers’ 
willingness to purchase biotech foods and a question on how often they read food labels while 
shopping. In the last section, information is collected regarding respondents’ socioeconomic 
and demographic characteristics (e.g., age, income, marital status, education, and so on). 
In order to meet the objectives of the study, a mail survey was conducted during the 
month of July 2002. Questionnaires were mailed to randomly selected 3,450 households for the 
seven metropolitan regions in the U.S.: Atlanta, Denver, Houston, Chicago, Los Angeles, New 
Orleans, and New York. Number of surveys mailed to Atlanta is 450, Denver 500, Houston 
500, Chicago 500, Los Angeles 500, New Orleans 500, and New York 500.  Five hundred 
twenty four (15% of sample) individuals responded, but not all of the returned surveys were 
completed. Only five hundred nine usable surveys were returned, for an overall response rate of 
14.75%.  
 
Results 
Summary statistics and frequency distributions of the socioeconomic and demographic 
variable information of the sample are presented in table 1. Out of 509 respondents, 54 % (274) 
are male and 46% (235) are female. About 64 % of those surveyed were married. All age 
groups are represented in the sample, with the 45-54 age groups representing 27% of the 
sample, and the majority of respondents (about 80%) were white. Most of the respondents are 
highly educated, as more than 80% finished some college course, completed bachelor degree,   15 
and did post graduate work. Thus, the responding sample is somewhat biased toward the white 
and higher-educated. The median income of respondents ranged from $30,000 to $44,999, 
accounting for 20% of the sample. Frequency distributions concerning respondents’ agreement 
or disagreement with the mandatory labeling versus voluntary labeling question are presented 
in Table 2. As shown, of the 509 respondents, 80% (409) support mandatory labeling policy for 
biotech products. Only 20% of respondents favor the voluntary labeling policy.  
The estimated models fit the data fairly well with a Chi-squared value of 482.941 for 
biotech nonmeat and 416.783 for biotech meat product, which are statistically significant at the 
a=0.01 level.  For the analysis, the differences of coefficients between indicator and reference 
choice are reported in tables 3, 4, and 5. For consumers’ preferences of labeling policy in both 
biotech crops and biotech meat products, voluntary labeling policy is an indicator choice and 
mandatory labeling policy is a reference choice. For consumers’ willingness to purchase 
biotech products, depending on voluntary and mandatory labeling policy, an indicator choice is 
when consumes are in the market, and a reference choice is when consumers are out of the 
market. The magnitudes of the differences are obtained from multinomial logit results by 
testing the null hypothesis that the differences between indicator and reference category are 
equal. Consumers’ labeling preferences for biotech foods from crops are presented in table 3, 
depending on whether consumers are in the market, they are out of the market, and they are 
uncertain about purchasing biotech foods.  
 
Consumer Preferences of Labeling Policy for Biotech Crops 
Consumers in the market  
The coefficient on statement S1 is significant at the a=0.10 significance level, and 
positive which suggests that as consumers consider that biotech foods are safe for human   16 
consumption, they are more likely to favor the current voluntary labeling policy. The estimated 
odds for individuals agreeing with statement S1 to support current labeling policy was 1.90 
times higher than a mandatory labeling policy. The coefficients on statement S2 and S5 have 
the expected signs and are significant at the a=0.01 level of significance. The odds ratio for 
adverse effects on the environment is 0.52, indicating that as respondents are aware of side 
effects of biotech crops on the wildlife and the environment, the odds in favor of current 
voluntary labeling decreases by a multiplicative factor of 0.52. This results support research 
hypothesis that unfavorable effect on the wildlife and the environment has negative effects on 
the probability of favoring current voluntary labeling policy. As consumers believe the U.S. 
Food and Drug Administration (FDA) as inspection agency of biotech foods, the odds of 
supporting current labeling policy is 1.51 times larger than mandatory labeling policy, which is 
consistent with our expectation.  
Consumers are out of the market 
The coefficients on consumer awareness of biotech foods and side effects on the 
environment of biotech foods are significant at the a=0.01 significance level. Results show that 
as consumers are well informed of biotechnology, they have stronger risk perceptions for 
biotech foods. A coefficient on consumer awareness of biotech biotechnology has a negative 
sign, as expected. The odds ratio that consumers of being informed more than somewhat are in 
favor of current labeling policy are 0.01, implying the more they are aware of biotechnology, 
the less they support current labeling by a multiplicative factor of 0.01. The estimated odds for 
those who recognize adverse effect on the environment of biotech foods to support current 
labeling policy is 0.03 smaller than mandatory labeling policy. The estimated coefficient on 
infant, age3, and income3 are statistically significant at the 0.01 level of significance. The odds   17 
ratio for consumers with infants, age group between 18 and 34, and income group more than 
$90,000 to support current labeling policy is extremely low compared to mandatory labeling 
policy, indicating that they are very concerned about health risk due to biotechnology. 
Consumers uncertain about purchasing biotech foods 
The estimated coefficients on statement S4 and S5 are statistically significant at the 
a=0.10 and a=0.01 level of significance, respectively. Results demonstrate that even though 
consumers agree that biotechnology benefits society by producing food more efficiently, they 
have an unfavorable attitude to current labeling policy, which is unexpected. The estimated 
odds for the current labeling policy is 0.55 times lower than mandatory labeling policy. One 
possible explanation is that consumers may distinguish society benefit from their own interest. 
However, the odds ratio of consumers supporting FDA as scientific and regulatory institution 
of biotech foods are in favor of current labeling policy is 2.88 times greater than mandatory 
labeling policy, which is consistent with our expectation. In terms of use of foods labels, which 
is significant at the a=0.01 significance level, the study reveals, as expected, that the more 
consumers read food labels of new products, the less they support current labeling policy. The 
estimated odds for the voluntary labeling policy are 0.18 times lower than the mandatory 
labeling policy, suggesting that consumers who are interested in reading food labels of new 
products are in favor of the mandatory labeling policy. 
Consumers’ labeling preferences for meat biotech foods are presented in table 4, 
according to consumers in the market, out of the market, and uncertain about purchasing 
biotech foods.  
 
Consumer Preferences for a Biotech Labeling Policy- Biotech Meat Products   18 
Consumers in the market 
Results show that as consumers are concerned adverse effects on the environment of 
biotech foods, they are more likely to support a mandatory labeling policy, which is expected. 
Statement S2 and S3 are statistically significant at the a=0.01 confidence level. The odds ratio 
of consumers who are conscious of side effects of biotech on wildlife and the environment 
support current labeling policy is 0.51 times lower than mandatory labeling policy, as 
predicted. However, results show that consumers agreeing with the statement that biotech meat 
products are more likely to pose health risk than biotech nonmeat products are in favor of 
current labeling policy by 1.70 times higher than mandatory labeling policy, which is 
unexpected. It is not clear how this result is obtained. Male respondents are significantly related 
to the probability of choosing mandatory labeling policy at the 0.05 significance level. The 
estimated odds for male is 0.34, suggesting the predicted odds for male to support current 
labeling policy decreases by a multiplicative factor of 0.34. 
Consumers out of the market 
Results reveal that the age of the respondent has a significant effect on the probability 
of choosing a labeling policy. The age group more than 55 is statistically significant at the 
a=0.10 level of significance, and of expected negative sign. This suggests that older 
respondents more than 55 be worry about unknown health risk of biotech foods, and thus are 
more likely to support mandatory labeling policy. The odds ratio is 0.27, indicating that that the 
odds for them to be in favor of current labeling policy decreases by a multiplicative factor of 
0.27. The estimated coefficient on statement S2 is statistically significant at the 0.01 level of 
significance. The estimated odds of consumers recognizing adverse effects on environment of 
biotech foods favor current labeling policy is 0.20 times smaller than mandatory labeling.    19 
Consumers uncertain about purchasing biotech foods 
Respondents’ trust for FDA as regulatory agency for biotech foods has positive and 
significant effect on the probability of choosing labeling policy. A coefficient on statement S5 
is significant at the a=0.01 significance level and has expected positive sign. The odds ratio of 
consumers trusting the U.S. Food and Drug Administration (FDA) as an inspection institution 
of biotech foods support current labeling policy is 2.17 times higher than mandatory labeling 
policy. This suggests that they are unfavorable of purchasing biotech foods, but they have 
confidence in government institution as regulatory agency of biotech foods. 
The results from table 3 and 4 suggest that in both biotech food from crops and meat 
biotech foods, when consumers are out of the market, they have relatively stronger risk 
sensitivity on environment of biotech foods. This results support research hypothesis that if 
consumers are out of the market, they are less in favor of current labeling policy, and they have 
stronger risk perceptions on wildlife and environment of biotech foods. Thus, they are more 
likely to support mandatory labeling policy. In addition, research hypothesis that risk sensitivity 
in biotech meat foods is greater than that in nonmeat biotech foods is supported from results in 
Table 3 and 4. Results demonstrate that when consumers are in the market and uncertain about 
purchasing biotech foods, the probability of supporting current labeling policy in biotech meat 
foods is lower than in biotech foods from crops.  
Table 5 presents consumers’ purchasing behavior for both crops and meat biotech foods 
according to the labeling preferences.  
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Consumer Willingness to Purchase – Food from Biotech Crops 
Support current  labeling policy 
The estimated coefficients on consumer awareness of biotech foods and statement S1 
are statistically significant at the a=0.01 confidence level, and of expected positive sign, 
respectively. The odds ratio for consumer awareness of biotech foods is 126.1, which suggests 
that the odds of buying biotech foods is 126.1 times larger than not buying as they get more 
informed of biotechnology. The estimated odds of consumers who feel safety of the biotech 
food for human consumption are willing to buy biotech foods is 112.7 times higher than not 
willingness to buy the same foods, indicating that these consumers are very favorable of 
purchasing biotech foods. For the adverse effect on environment of biotech foods, we expected 
lower odds of buying biotech foods, but the results shows higher odds. Education level of 
consumers, which is significant at the 0.10 confidence level, has positive and significant effect 
on the probability of purchasing biotech foods. Consumers with education level of more than 
college are more likely to be willingness to buy biotech foods.  The odds ratio for education is 
14.1, implying that the odds that consumers with more than college level buy biotech foods is 
higher by a multiplicative factor of 14.1. 
 
Support mandatory labeling policy 
Results show that the estimated coefficients on statement S4 and S6 are statistically 
significant at the 0.01 confidence level, and of the expected positive and negative sign, 
respectively. This suggest that as consumers believe that biotechnology provides benefit to 
society by allowing farmer to produce more efficiently with less waste and fewer pesticides, 
they are more likely to purchase biotech foods. The estimated odds of consumers agreeing 
biotechnology benefit for society purchase biotech foods is 2.56 times greater than not   21 
purchasing those. However, consumers who believe that biotechnology is morally wrong by 
producing hybrid plants and animal are less likely to buy biotech foods. As consumers 
recognize immorality of biotechnology, the odds for them to buy biotech foods is 0.38 times 
lower. This result suggests that morality of biotechnology is significant factor to determine 
consumers’ purchasing behavior of biotech foods. 
 
Consumer Willingness to Purchase – Biotech Meat Products 
Support current labeling policy 
It is expected that if consumers believe that biotech meats are more likely to pose health 
risks relative to nonmeat food, then they are less likely to purchase biotech meats. A negative 
sign of statement S3, which is statistically significant at the 0.05 significance level, provides 
evidence. Results show that the estimated odds that consumers who are aware of more likely 
health risk from biotech meat foods purchase biotech meats is 0.28 times lower relative to not 
buying that foods. As consumers trust FDA as regulatory agency of biotech foods, it is 
expected a positive impact on the probability of purchasing biotech foods. However, result 
shows unexpected negative sign.   
Support mandatory labeling policy 
The race variable turned out to be significant in purchasing biotech meats at the 0.05 
confidence level. The estimated odd for white is 2.68, indicating that the odds for white to 
purchase biotech foods rather than not purchasing is 2.68 times higher. It is anticipated that the 
more consumer read foods labels of new products, the less they purchase biotech foods when 
they prefer mandatory labeling policy. This expectation is supported from a negative sign and   22 
0.38 odds ratio of consumer use of foods labels variable, which is significant at the 0.05 
significance level. 
From the analysis in table 5, two important implications have been drawn. First, when 
consumers indicate they prefer the current FDA policy in agreement with statement S1, S2, S3, 
and S5, all lead to smaller odds that a consumer would buy a biotech meat products, relative to 
nonmeat product. This is also the case for the statement S1 through S4 if consumer indicates 
they prefer a mandatory labeling policy. Therefore, consumers are generally less willing to 
purchase biotech meat under either labeling relative to biotech nonmeats. Thus, research 
hypothesis that consumers are more concerned about biotech meat foods relative to nonmeat 
foods is supported. This finding is consistent with Hallman and Metcalfe’s study (1994), which 
demonstrated consumers are less likely to accept the use of biotechnology with meat products 
produced using biotechnology. Secondly, table 5 shows that the odds ratio in mandatory 
labeling relative to voluntary labeling policy is generally smaller for both nonmeat and meat 
cases, which means that consumers are less likely to purchase biotech foods under a mandatory 
labeling policy.  
 
Conclusions 
This study conducted a national survey to investigate the effects of consumers’ risk 
perceptions of biotech foods on attitudes toward the current U.S. labeling policy for biotech 
foods. A multinomial logit analysis is used to examine the effects of risk perceptions of biotech 
foods on consumer preferences for mandatory and voluntary labeling and consumers’ 
purchasing behavior of biotech foods depending on labeling policy. Results show that if 
consumers are not willing to buy biotech foods, then they are less likely to favor voluntary   23 
labeling policy and have stronger risk sensitivity to potential negative effects of biotech foods 
on wildlife and the environment. In addition, this study reveals that when consumers are in the 
market or uncertain about purchasing biotech foods, the odds of them supporting the current 
labeling policy for biotech meats is lower than in biotech foods made from crops. Results 
support the hypothesis that consumers are less likely to purchase biotech foods under a 
mandatory labeling policy.  
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Table 1. Frequency Distribution of Socio-Demographic Characteristics of Survey  
                 Respondents of Biotech Labeling Survey 
Demographic Characteristics 
     Sample (n= 509) 
Number  Percentage 
Gender                        
Male   274  54.0 
Female  235  46.0 
     
Age (years)     
18-24   12  2.36 
25-34  56  11.00 
35-44  99  19.45 
45-54  135  26.52 
55-65  93  18.27 
65 or older  114  22.40 
     
Education     
Less than high school  2  0.39 
Completed High school  58  11.39 
Technical school  37  7.27 
Some college  119  23.88 
Completed bachelor degree   150  29.47 
Post graduate work  143  28.09 
     
Income     
Less than $15,000  33  6.48 
$15,000 -$29,000  47  9.23 
$30,000 - $44,999  101  19.84 
$45,000 - $59,999  99  19.45 
$60,000 -$74,999   76  14.93 
$75,000 -$89,999  53  10.41 
$90,000 -$104,999  32  6.29 
$105,000 -$119,999  19  3.73 
More than $120,000  49  9.63 
 
 
 
 
Table 2. Respondent’s Responses to a Mandatory or Voluntary  
                 Labeling Policy. 
  Number of Respondents  Percentage of Respondents 
Voluntary Labeling  103  20 
Mandatory Labeling  406  80   28 
Table 3. Consumers’ Labeling Preferences Given Purchasing Behavior for Biotech Foods from Crops 
In the Market  Out of the  Market  UNCERTAIN 
Current Policy vs. Mandatory  Current Policy vs. Mandatory  Current Policy vs. Mandatory 
 
 
Variable  Coeff. 
(Std.Err.) 
Exp(ß)
1)  Coeff. 
(Std.Err.) 
Exp(ß)  Coeff. 
(Std .Err) 
Exp(ß) 
Constant Term  -2.484 
(1.754) 
0.08  14.855 
(6.772) 
2)  -0.695 
(2.285) 
0.50 
Consumer Awareness of Biotech Foods  0.478 
(0.342) 
1.61  -4.405*** 
(1.490) 
0.01  -0.259 
(0.516) 
0.77 
S1. Biotech Foods are reasonably safe for human consumption.  0.644* 
(0.366) 
1.90  -2.087 
(1.703) 
0.12  -0.312 
(0.371) 
0.73 
S2. Biotech crops may have adverse effects on  wildlife and the   
      environment. 
-0.657*** 
(1.193) 
0.52  -3.453*** 
(0.943) 
0.03  -0.062 
(0.249) 
0.94 
S3. Meat products produced using biotechnology are  more likely   
      to pose health risks than foods made from biotech crops. 
0.200 
(0.208) 
1.22  -0.189 
(0.684) 
0.83  -0.265 
(0.273) 
0.77 
S4. Biotechnology benefits society because it allows  farmers to  
       produce food more efficiently. 
-0.277 
(0.339) 
0.76  1.099 
(0.711) 
3.00  -0.592* 
(0.328) 
0.55 
S5. There is no need to be concerned about the safety of biotech   
       foods because the U.S. Food  and Drug Administration  
       (FDA) would not  let these products be sold in supermarket  
       if they were not safe.             
0.410*** 
(0.157) 
1.51  0.372 
(0.538) 
1.45  1.059*** 
(0.231) 
2.88 
S6. It is unethical to produce a food using biotechnology.  -0.146 
(0.237) 
0.86  -0.340 
(0.589) 
0.71  0.237 
(0.269) 
1.27 
Infants  -0.797 
(0.868) 
0.45  -29.111*** 
(1.791) 
2.28
-13  -1.724* 
(0.944) 
0.18 
Male  -0.371 
(0.352) 
0.69  -1.701 
(1.390) 
0.18  -0.611 
(0.509) 
0.54 
           
-0.561 
(0.574) 
0.57  -33.964*** 
(3.215) 
1.78
-15  -0.186 
(0.718) 
0.83 
Age 
       Age1 (age group between 18 and 34) 
       
       Age3 (age group more than 55)  -0.391 
(0.362) 
0.68  0.596 
(2.537) 
1.81  -0.499 
(0.562) 
0.61 
Income             
      Income1 (income group less than $44,999)  0.142 
(0.423) 
1.15  1.210 
(0.957) 
3.35  0.775 
(0.546) 
2.17 
      Income 3 (income group more than $90,000)  0.687* 
(0.388) 
1.99  -29.479*** 
(1.294) 
1.58
-13  -0.168 
(0.865) 
0.85 
* ,**,***, indicates estimated coefficient is significant at the  0.10, 0.05, and 0.01 level, respectively. N = 509; Chi-square (c 
2)= 482.941; Log-L=-519.414; 
1) is odds ratio. 
2) 
indicates large odds ratio.   29 
Contiuned. 
 
In the Market  Out of the Market  UNCERTAIN 
Current Policy vs. Mandatory  Current Policy vs. Mandatory  Current Policy vs. Mandatory 
 
 
Variable  Coeff. 
(Std.Err.) 
Exp(ß)
1)  Coeff. 
(Std.Err.) 
Exp(ß)  Coeff. 
(Std.Err.) 
Exp(ß) 
Education 
 
0.313 
(0.598) 
1.37  -2.290 
(1.421) 
0.10  0.163 
(0.576) 
1.18 
Married 
 
-0.463 
(0.371) 
0.63  -0.592 
(0.866) 
0.55  0.464 
(0.450) 
1.59 
White 
 
0.220 
(0.472) 
1.25  -0.156 
(0.919) 
0.86  0.133 
(0.496) 
1.14 
How often do you read the ingredient section of 
food labels before buying a new product? 
-0.291 
(0.368) 
0.75  -1.653 
(1.760) 
0.19  -1.734*** 
(0.518) 
0.18 
* ,**,***, indicates estimated coefficient is significant at the  0.10, 0.05, and 0.01 level, respectively. N = 509; Chi-square (c 
2)= 482.941; Log-L=-519.414; 
1) is odds ratio 
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Table 4. Consumers’ Labeling Preferences Given Purchasing Behavior for Meat Biotech Foods  
In the Market  Out of the  Market  UNCERTAIN 
Current Policy vs. Mandatory  Current Policy  vs. Mandatory  Current Policy vs. Mandatory 
 
 
Variable  Coeff. 
(Std.Err.) 
Exp(ß)
1)  Coeff. 
(Std.Err.) 
Exp(ß)  Coeff. 
(Std .Err) 
Exp(ß) 
Constant Term  -1.467 
(2.562) 
0.23  3.012 
(2.857) 
20.3  -1.245 
(1.807) 
0.29 
Consumer Awareness of Biotech Foods  0.667 
(0.442) 
1.95  -0.122 
(0.554) 
0.89  0.065 
(0.430) 
1.07 
S1. Biotech Foods are reasonably safe for human consumption.  0.720 
(0.485) 
2.05  -0.034 
(0.582) 
0.97  -0.165 
(0.306) 
0.85 
S2. Biotech crops may have adverse effects on  wildlife and the   
      environment. 
-0.680*** 
(0.227) 
0.51  -1.616*** 
(0.443) 
0.20  -0.136 
(0.219) 
0.87 
S3. Meat products produced using biotechnology are  more likely   
      to pose health risks than foods made from biotech crops. 
0.528*** 
(0.265) 
1.70  0.701 
(0.478) 
2.02  -0.219 
(0.235) 
0.80 
S4. Biotechnology benefits society because it allows  farmers to  
       produce food more efficiently. 
-0.052 
(0.440) 
0.95  -0.396 
(0.422) 
0.67  -0.210 
(0.78) 
0.81 
S5. There is no need to be concerned about the safety of biotech   
        foods because the U.S. Food  and Drug Administration  
        (FDA) would not  let these products be sold in supermarket  
        if they were not safe.             
0.117 
(0.192) 
1.12  1.094*** 
(0.319) 
2.99  0.777*** 
(0.170) 
2.17 
S6. It is unethical to produce a food using biotechnology.  -0.265 
(0.308) 
0.77  -0.550 
(0.413) 
0.58  0.165 
(0.207) 
1.18 
Infants  -0.986 
(0.878) 
0.37  -28.443*** 
(0.728) 
4.44
-13  -1.247 
(1.042) 
0.29 
Male  -1.091** 
(0.485) 
0.34  -0.085 
(0.644) 
0.92  -0.227 
(0.414) 
0.80 
           
0.067 
(0.709) 
1.07  -1.101 
(0.844) 
0.33  -0.581 
(0.681) 
0.56 
Age 
       Age1 (age group between 18 and 34) 
       
       Age3 (age group more than 55)  0.081 
(0.453) 
1.08  -1.310* 
(0.687) 
0.27  -0.637 
(0.473) 
0.53 
Income             
      Income1 (income group less than $44,999)  0.422 
(0.531) 
1.53  0.327 
(0.745) 
1.39  0.582 
(0.464) 
1.79 
      Income 3 (income group more than $90,000)  0.512 
(0.475) 
1.67  0.327 
(0.855 
1.39  0.372 
(0.574) 
1.45 
* ,**,***, indicates estimated coefficient is significant at the  0.10, 0.05, and 0.01 level, respectively. N = 509; Chi-square (c 
2)= 416.783; Log-L=-568.967; 
1) is odds ratio   31 
Contiuned. 
 
In the Market  Out of the Market  UNCERTAIN 
Current Policy vs. Mandatory  Current Policy vs. Mandatory  Current Policy vs. Mandatory 
 
 
Variable  Coeff. 
(Std.Err.) 
Exp(ß)
1)  Coeff. 
(Std.Err.) 
Exp(ß)  Coeff. 
(Std.Err.) 
Exp(ß) 
Education 
 
-0.212 
(0.765) 
0.81  -0.215 
(0.804) 
0.81  -0.367 
(0.543) 
0.69 
Married 
 
-0.261 
(0.456) 
0.77  -1.524*** 
(0.469) 
0.22  0.505 
(0.450) 
1.66 
White 
 
0.416 
(0.724) 
1.52  0.365 
(0.599) 
1.44  -0.404 
(0.433) 
0.67 
How often do you read the ingredient section of 
food labels before buying a new product? 
-0.529 
(0.442) 
0.59  -1.101 
(0.698) 
0.33  -0.639 
(0.443) 
0.53 
* ,**,***, indicates estimated coefficient is significant at the  0.10, 0.05, and 0.01 level, respectively. N = 509; Chi-square (c 
2)=416.783; Log-L=-568.967; 
1) is odds ratio 
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Table 5. Consumers’ Purchasing Behavior for Both Crops and Meat Biotech Foods Given Labeling Preferences 
NONMEAT  MEAT 
Current Policy   Mandatory  Current Policy   Mandatory 
In the Market 
vs. 
Out of the Market 
In the Market 
vs. 
Out of the Market 
In the Market 
vs. 
Out of the Market 
In the Market 
vs. 
Out of the Market 
 
 
 
 
 
Variable  Coeff. 
(Std. Err) 
Exp(ß)
1)  Coeff. 
(Std. Err) 
Exp(ß)  Coeff 
(Std. Err). 
Exp(ß)  Coeff. 
(Std. Err) 
Exp(ß). 
Constant Term  -23.534 
(6.429) 
6.01
-11  -6.195 
(2.120) 
2.04
-03  -7.205 
(1.944) 
7.43
-04  -2.719 
(2.195) 
0.07 
Consumer awareness of biotech foods  4.837*** 
(1.409) 
126.1  0.385 
(0.415) 
1.47  -0.181 
(0.171) 
0.83  -0.370 
(0.437) 
0.69 
S1. Biotech Foods are reasonably safe for human consumption.  4.725*** 
(1.698) 
112.7  1.994*** 
(0.388) 
7.34  1.943*** 
(0.693) 
6.98  1.189*** 
(0.238) 
3.28 
S2. Biotech crops may have adverse effects on  wildlife and the   
      environment. 
2.757*** 
(0.927) 
15.8  -0.039 
(0.267) 
0.96  0.574 
(0.448) 
1.78  -0.363 
(0.241) 
0.70 
S3. Meat products produced using biotechnology are  more likely   
      to pose health risks than foods made from biotech crops. 
0.218 
(0.651) 
1.24  -0.171 
(0.318) 
0.84  -1.274** 
(0.506) 
0.28  -1.101*** 
(0.282) 
0.33 
S4. Biotechnology benefits society because it allows  farmers to  
       produce food more efficiently. 
-0.188 
(0.752) 
0.83  0.939*** 
(0.281) 
2.56  0.799 
(0.552) 
2.22  0.455 
(0.300) 
1.58 
S5. There is no need to be concerned about the safety of biotech   
        foods because the U.S. Food  and Drug Administration  
        (FDA) would not  let these products be sold in supermarket  
        if they were not safe.             
-0.125 
(0.524) 
0.88  -0.163 
(0.226) 
0.85  -0.748** 
(0.333) 
0.47  0.230 
(0.192) 
1.26 
S6. It is unethical to produce a food using biotechnology.  -0.777 
(0.612) 
0.46  -0.972*** 
(0.334) 
0.38  -0.299 
(0.465) 
0.74  -0.584** 
(0.258) 
0.56 
Infants  28.185*** 
(2.065) 
2)  -0.130 
(1.085) 
0.88  28.434*** 
(1.009) 
4)  0.982 
(0.953) 
2.67 
Male  2.151 
(1.381) 
8.60  0.821* 
(0.431) 
2.27  0.511 
(0.696) 
1.67  1.517*** 
(0.443) 
4.56 
Age                 
       Ag1 (age group between 18 and 34)  33.663*** 
(3.265) 
3)  0.260 
(0.644) 
1.30  0.959 
(0.918) 
2.61  -0.209 
(0.667) 
0.81 
       Age3 (age group more than 55)  -0.660 
(2.527) 
0.52  0.327 
(0.441) 
1.39  1.689** 
(0.722) 
5.41  0.297 
(0.423) 
1.35 
Income                 
*,**,***, indicates estimated coefficient is significant at the  0.10, 0.05, and 0.01 level, respectively. N = 509. For crop Chi-square (c 
2)= 482.941; Log-L=-519.414, and for meat 
Chi-square (c 
2)=416.783; Log-L=-568.967;
 1) is odds ratio. 
2), 
3), and 
4) indicate large odds ratio. 
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Continued. 
NONMEAT  MEAT 
Current Policy   Mandatory  Current Policy   Mandatory 
In the Market 
vs 
Out of the Market 
In the Market 
vs 
Out of the Market 
In the Market 
vs 
Out of the Market 
In the Market 
vs 
Out of the Market 
 
 
 
 
 
Variable  Coeff. 
(Std. Err.) 
Exp(ß)
1)  Coeff. 
(Std. Err.) 
Exp(ß)  Coeff. 
(Std. Err.) 
Exp(ß)  Coeff. 
(Std. Err.) 
Exp(ß) 
       Income 1 (income group less than $44,999) 
 
-0.369 
(0.947) 
0.69  0.699 
(0.461) 
2.01  0.078 
(0.808) 
1.08  -0.018 
(0.449) 
0.98 
       Income 3 (income group more than $90,000)  30.186*** 
(1.284) 
2)  0.021 
(0.534) 
1.02  0.599 
(0.877) 
1.82  0.414 
(0.496) 
1.51 
Education (more than college)  2.648* 
(1.416) 
14.1  0.045 
(0.681) 
1.05  1.306 
(0.905) 
3.69  1.303* 
(0.702) 
3.68 
Married 
 
0.541 
(0.845) 
1.71  0.413 
(0.465) 
1.51  0.873 
(0.531) 
2.39  -0.392 
(0.436) 
0.68 
White 
 
0.469 
(0.945) 
1.60  0.093 
(0.489) 
1.10  1.035 
(0.839) 
2.82  0.984** 
(0.476) 
2.68 
 How often do you read the ingredient section of food labels     
  before buying a new product? 
1.771 
(1.724) 
5.88  0.410 
(0.527) 
1.51  -0.396 
(0.679) 
0.67  -0.967** 
(0.488) 
0.38 
* ,**,***, indicates estimated coefficient is significant at the  0.10, 0.05, and 0.01 level, respectively. N = 509. For crop Chi-square (c 
2)= 482.941; Log-L=-519.414, and for meat 
Chi-square (c 
2)=416.783; Log-L=-568.967;
 1) is odds ratio. 
2) indicates large odds ratio. 
 
 